Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles.

scientific article published on 29 October 2014

Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BIOMATERIALS.2014.10.007
P698PubMed publication ID25453970
P5875ResearchGate publication ID269171188

P50authorShaobo RuanQ48401233
Huile GaoQ56954141
P2093author name stringLi Zhang
Yuting Yang
Qin He
Mingqing Yuan
Qianyu Zhang
Guanlian Hu
Jiantao Chen
Xingli Cun
P921main subjectdoxorubicinQ18936
nanoparticleQ61231
P304page(s)425-435
P577publication date2014-10-29
P1433published inBiomaterialsQ15751139
P1476titleTumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles
P478volume37

Reverse relations

cites work (P2860)
Q54007900A novel αVβ3 ligand-modified HPMA copolymers for anticancer drug delivery.
Q38976142Acidity-Induced Destabilization of Nano-Sized Supramolecular Linear-Hyperbranched Polymersome for Controlled Release of Encapsulated Cargoes
Q38838668Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.
Q90676304Application of the Tumor Site Recognizable and Dual-Responsive Nanoparticles for Combinational Treatment of the Drug-Resistant Colorectal Cancer
Q59136285Biosynthesis of flower-shaped Au nanoclusters with EGCG and their application for drug delivery
Q38836486Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery
Q30362001Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment.
Q38401892Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor
Q38867245Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo
Q57371050Design of pH-responsive gold nanoparticles in oncology
Q92190033Development and application of hyaluronic acid in tumor targeting drug delivery
Q26778787Development of targeted therapies in treatment of glioblastoma
Q36042421Dual Receptor-Targeted Theranostic Nanoparticles for Localized Delivery and Activation of Photodynamic Therapy Drug in Glioblastomas.
Q30362004Dual-targeted and pH-sensitive Doxorubicin Prodrug-Microbubble Complex with Ultrasound for Tumor Treatment.
Q93015091Dual-targeting and microenvironment-responsive micelles as a gene delivery system to improve the sensitivity of glioma to radiotherapy
Q53697170Effect of Chemical Binding of Doxorubicin Hydrochloride to Gold Nanoparticles, Versus Electrostatic Adsorption, on the In Vitro Drug Release and Cytotoxicity to Breast Cancer Cells.
Q90445991Engineered superparamagnetic iron oxide nanoparticles (SPIONs) for dual-modality imaging of intracranial glioblastoma via EGFRvIII targeting
Q38678020Engineering β-sheet peptide assemblies for biomedical applications
Q64230507Enhanced Radiosensitization by Gold Nanoparticles with Acid-Triggered Aggregation in Cancer Radiotherapy
Q58549959Enhanced blood-brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles
Q47201613Fabrication, Characterization and Cytotoxicity of Spherical-Shaped Conjugated Gold-Cockle Shell Derived Calcium Carbonate Nanoparticles for Biomedical Applications
Q37026387Fluorescent-Guided Surgical Resection of Glioma with Targeted Molecular Imaging Agents: A Literature Review
Q47933145Glioma targeted delivery strategy of doxorubicin-loaded liposomes by dual-ligand modification
Q37137190Gold Nanoparticle-Mediated Targeted Delivery of Recombinant Human Endostatin Normalizes Tumour Vasculature and Improves Cancer Therapy
Q49233935Gold Nanoparticles-enabled Efficient Dual Delivery of Anticancer Therapeutics to HeLa Cells.
Q55154596H2O2-Responsive Nanoparticle Based on the Supramolecular Self-Assemble of Cyclodextrin.
Q38750556Hyaluronic acid-coated, prodrug-based nanostructured lipid carriers for enhanced pancreatic cancer therapy
Q92070861Impact of Medium pH on DOX Toxicity toward HeLa and A498 Cell Lines
Q52561274Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy - An illustration with firsthand examples.
Q47960548Improving gold nanorod delivery to the central nervous system by conjugation to the shuttle Angiopep-2.
Q39375298Matrix metalloproteases-responsive nanomaterials for tumor targeting diagnosis and treatment.
Q38882705Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma.
Q52761279Membrane heat shock protein 70: a theranostic target for cancer therapy.
Q92435790Menthol-modified casein nanoparticles loading 10-hydroxycamptothecin for glioma targeting therapy
Q37668050Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma
Q58767702Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting
Q41018587Penetration of blood-brain barrier and antitumor activity and nerve repair in glioma by doxorubicin-loaded monosialoganglioside micelles system
Q47933170Peptide Mediated Brain Delivery of Nano- and Submicroparticles: a Synergistic Approach.
Q60184483Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications
Q36562350Peptide mediated active targeting and intelligent particle size reduction-mediated enhanced penetrating of fabricated nanoparticles for triple-negative breast cancer treatment
Q38969029Peptides as a therapeutic avenue for nanocarrier-aided targeting of glioma
Q55348014Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery.
Q38857119Perspectives on Dual Targeting Delivery Systems for Brain Tumors.
Q26740580Progress and perspectives on targeting nanoparticles for brain drug delivery.
Q45871459RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials
Q57377867Radioactive (Y) upconversion nanoparticles conjugated with recombinant targeted toxin for synergistic nanotheranostics of cancer
Q37636271Receptor-Mediated Drug Delivery Systems Targeting to Glioma
Q90746966Reversible encapsulations and stimuli-responsive biological delivery from a dynamically assembled cucurbit[7]uril host and nanoparticle guest scaffold
Q33820994Self-Assembly of Gold Nanoparticles Shows Microenvironment-Mediated Dynamic Switching and Enhanced Brain Tumor Targeting
Q92539527Size and time-dependent induction of proinflammatory cytokines expression in brains of mice treated with gold nanoparticles
Q38662677Strategies for transporting nanoparticles across the blood-brain barrier
Q38643071Strategies to release doxorubicin from doxorubicin delivery vehicles
Q28071773Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and Uses
Q48225985Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.
Q52696588Synthesis of gold nanomaterials and their cancer-related biomedical applications: an update.
Q52371355Target delivery of doxorubicin tethered with PVP stabilized gold nanoparticles for effective treatment of lung cancer.
Q57291853Targeted Theranostic Nanoparticles for Brain Tumor Treatment
Q89939081Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles
Q92240603The Physicochemical Properties of Graphene Nanocomposites Influence the Anticancer Effect
Q38407992The Use of Anthracyclines for Therapy of CNS Tumors.
Q36445146Thermosensitive Hydrogel Co-loaded with Gold Nanoparticles and Doxorubicin for Effective Chemoradiotherapy
Q36652635Translocation of LRP1 targeted carbon nanotubes of different diameters across the blood-brain barrier in vitro and in vivo
Q53101640Tumor Microenvironment in Treatment of Glioma.

Search more.